Euclid Systems Launches New Euclid MAX Ortho-K Lens

Euclid Systems announced the United States launch of the overnight orthokeratology lens Euclid MAX. Used in children and adult patients with progressive myopia, but especially children, Ortho-K contact lenses gently reshape the cornea to manage myopia while the patient sleeps. 

“Euclid MAX is the next generation of Ortho-K,” Euclid Systems CEO Joseph Boorady said in a company news release. “Building on Euclid’s proprietary lens designs, Euclid MAX features an innovative material with a Hyper Dk of 180, the highest of any US overnight Ortho-K brand, without the compromise of lens stability. This is especially important with young healthy eyes in the closed eye environment. We are very proud and excited to introduce this combination of outstanding material characteristics and proven lens designs, which will help more patients successfully manage their myopia.”

Following FDA approval, Euclid gave early access to Euclid MAX to a limited group of optometrists over the last few months to get real-world clinical experience on patients’ eyes. In a survey of this early access group who had experience fitting the lens, 100% of the respondents replied they would consider recommending Euclid MAX to their next patient.⁶

“Euclid Max provides incredible oxygen permeability, lens stability, and wettability, which adds a layer of comfort, safety, and satisfaction to my Ortho-K practice,” says David Kading, OD, FAAO, of Specialty Eyecare Group and an early access participant. 

Euclid will host two live roundtable discussions focused on innovation with today’s top Ortho-K practitioners.  “Shifting the Paradigm: Maximize Performance with the Next Generation of Ortho-K Lenses” will be held on Wednesday, May 19, and Thursday, May 20. For more details and to register for either or both sessions, go to:  https://tinyurl.com/9pfcz8un

To learn more about Euclid MAX and Euclid’s contribution to the battle against myopia, visit www.euclidsys.com.

References

1. Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. May 2016;123(5):1036–1042.
2. “Myopia Occurring Earlier: Specialist,” China Daily. June 7, 2018.
3. Younan C, Mitchell P, Cumming RG, Rochtchina E, Wang JJ. Myopia and incident cataract and cataract surgery: the BlueMountains eye study. Investigative Ophthalmology & Visual Science. 2002;43:3625-32.
4. Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999;106:2010-5.
5. Group TEDC-CS. Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group. American Journal of Epidemiology. 1993;137:749-57.
6. Data on file. Euclid Systems Corporation.